Sands Capital disclosed decreased in ULTRAGENYX PHARMACEUTICAL IN

Sands Capital filed a 13F change in ULTRAGENYX PHARMACEUTICAL IN (90400D108) on 2026-05-08, covering period end 2026-03-31.

Action

Decreased

Capital

$12,827,186 reported value

Why it matters

This signal is anchored to the SEC filing date while retaining the underlying 13F period end.

Sands Capital filed a 13F change in BLOOM ENERGY CORP (93712107) on 2026-05-08, covering period end 2026-03-31.

Sands Capital filed a 13F change in SEAGATE TECHNOLOGY HLDNGS PL (G7997R103) on 2026-05-08, covering period end 2026-03-31.